On March 4, 2021, the board of directors (the Board) of Allena Pharmaceuticals, Inc. (the Company) established June 3, 2021,
as the date for the Companys 2021 Annual Meeting of Stockholders (the Annual Meeting) and set April 5, 2021, as the record date for the Annual Meeting. Due to the fact that the date of the Annual Meeting has been changed by
more than thirty (30) days from the anniversary date of the 2020 Annual Meeting of Stockholders, the Company is providing the due date for submission of any qualified stockholder proposal or qualified stockholder nominations.
In accordance with Rule
under the Securities
Exchange Act of 1934, as amended (the Exchange Act), and the Companys amended and restated bylaws (the Bylaws), the deadline for receipt of stockholder proposals or nominations for inclusion in the Companys proxy
statement for the Annual Meeting pursuant to Rule
will be no later than 5:00 p.m., Eastern Time, March 15, 2021, or the tenth (10
following this public announcement of the meeting date. Stockholder proposals must comply with all of the applicable requirements set forth in the rules and regulations of the Securities and Exchange Commission, including Rule
under the Exchange Act and the Bylaws. Stockholder proposals and director nominations should be addressed to our Secretary, c/o Allena Pharmaceuticals, Inc., One Newton Executive Park, Suite 202, Newton, MA
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: March 5, 2021
Allena Pharmaceuticals, Inc.
/s/ Richard D. Katz
Richard D. Katz, MD
Chief Financial Officer
makes a similar move, sign up!
Other recent filings from the company include the following: